Requirement of pharmacological treatment for primary prevention of cardiovascular disease in asymptomatic office-executives in north-India.

MLA

Kasliwal, Ravi R., et al. “Requirement of Pharmacological Treatment for Primary Prevention of Cardiovascular Disease in Asymptomatic Office-Executives in North-India.” Indian Heart Journal, vol. 62, no. 4, July 2010, pp. 324–29. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21280473&authtype=sso&custid=ns315887.

APA

Kasliwal, R. R., Bansal, M., Mehrotra, R., Agrawal, V., & Shrivastava, S. (2010). Requirement of pharmacological treatment for primary prevention of cardiovascular disease in asymptomatic office-executives in north-India. Indian Heart Journal, 62(4), 324–329.

Chicago

Kasliwal, Ravi R, Manish Bansal, Rahul Mehrotra, Vinayak Agrawal, and Sameer Shrivastava. 2010. “Requirement of Pharmacological Treatment for Primary Prevention of Cardiovascular Disease in Asymptomatic Office-Executives in North-India.” Indian Heart Journal 62 (4): 324–29. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21280473&authtype=sso&custid=ns315887.